{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T05:32:21Z","timestamp":1709184741153},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00393-017-0364-7","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T20:22:07Z","timestamp":1506716527000},"page":"63-74","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zytopenien"],"prefix":"10.1007","volume":"76","author":[{"given":"C.","family":"Kneitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"issue":"1","key":"364_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.55.3.162","volume":"55","author":"HR Peeters","year":"1996","unstructured":"Peeters HR, Jongen-Lavrencic M, Raja AN et al (1996) Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 55(1):162\u2013168","journal-title":"Ann Rheum Dis"},{"key":"364_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrrheum.2012.183","volume":"9","author":"G Weiss","year":"2013","unstructured":"Weiss G, Schett G (2013) Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol 9:205\u2013215","journal-title":"Nat Rev Rheumatol"},{"key":"364_CR3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00393-011-0925-0","volume":"71","author":"M Wahle","year":"2012","unstructured":"Wahle M (2012) Anaemia in patients with rheumatoid arthritis. Z\u00a0Rheumatol 71:864\u2013868","journal-title":"Z Rheumatol"},{"key":"364_CR4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J\u00a0Clin Invest 113:1271\u20131276","journal-title":"J Clin Invest"},{"key":"364_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2002-01-0136","volume":"100","author":"HA Papadaki","year":"2002","unstructured":"Papadaki HA, Kritikos HD, Valatas V et al (2002) Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 100:474\u2013482","journal-title":"Blood"},{"key":"364_CR6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajh.23110","volume":"87","author":"CC Sun","year":"2013","unstructured":"Sun CC, Vaja V, Babitt JL et al (2013) Targeting the Hepcidin-Ferroportin Axis to Develop New Treatment Strategies for Anemia of Chronic Disease and Anemia of Inflammation. Am J Hematol 87:392\u2013400","journal-title":"Am J Hematol"},{"key":"364_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2257.1984.tb00561.x","volume":"6","author":"OP Hansen","year":"1984","unstructured":"Hansen OP, Hansen TM, Jans H, Hippe E (1984) Red blood cell membrane-bound IgG: demonstration of antibodies in patients with autoimmune haemolytic anaemia and immune complexes in patients with rheumatic diseases. Clin Lab Haematol 6:341\u2013349","journal-title":"Clin Lab Haematol"},{"key":"364_CR8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-100-2-202","volume":"100","author":"EN Dessypris","year":"1984","unstructured":"Dessypris EN, Baer MR, Sergent JS et al (1984) Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med 100:202\u2013206","journal-title":"Ann Intern Med"},{"key":"364_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar1803","volume":"7","author":"F Capsoni","year":"2005","unstructured":"Capsoni F, Sarzi-Puttini P, Zanella A (2005) Primary and secondary autoimmune neutropenia. Arthritis Res Ther 7:208\u2013214","journal-title":"Arthritis Res Ther"},{"key":"364_CR10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI109556","volume":"64","author":"G Starkebaum","year":"1979","unstructured":"Starkebaum G, Arend WP (1979) Neutrophil-binding immunoglobulin G in systemic lupus erythematosus. J\u00a0Clin Invest 64:902\u2013912","journal-title":"J Clin Invest"},{"key":"364_CR11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2014-02-482612","volume":"124","author":"C Gibson","year":"2014","unstructured":"Gibson C, Berliner N (2014) How we evaluate and treat neutropenia in adults. Blood 124:1251","journal-title":"Blood"},{"key":"364_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.semarthrit.2015.05.009","volume":"45","author":"C Linda","year":"2015","unstructured":"Linda C, Chiara T, Sabrina V (2015) Leukopenia, lymphopenia, and neutropenia in systemic lupus erythematosus: Prevalence and clinical impact\u2014A systematic literature review. Sem. Arthritis Rheum 45:190\u2013194","journal-title":"Arthritis Rheum"},{"key":"364_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jbspin.2015.01.005","volume":"82","author":"E Lazaro","year":"2015","unstructured":"Lazaro E, Morel J (2015) Management of neutropenia in patients with rheumatoid arthritis. Joint Bone Spine 82:235\u2013239","journal-title":"Joint Bone Spine"},{"key":"364_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jbspin.2015.02.012","volume":"82","author":"C Duquenne","year":"2015","unstructured":"Duquenne C, Cornec D, Marhadour T et al (2015) Lymphopenia in early arthritis: Impact on diagnosis and 3-year outcomes (ESPOIR cohort). Joint Bone Spine 82:417\u2013442","journal-title":"Joint Bone Spine"},{"key":"364_CR15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203313493032","volume":"22","author":"A Danza","year":"2013","unstructured":"Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286\u20131294","journal-title":"Lupus"},{"key":"364_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874312901307010087","volume":"7","author":"F Bashal","year":"2013","unstructured":"Bashal F (2013) Hematological Disorders in Patients with Systemic Lupus Erythematosus. Open Rheumatol\u00a0J 7:87\u201395","journal-title":"Open Rheumatol J"},{"key":"364_CR17","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","volume":"2","author":"A Fayyaz","year":"2015","unstructured":"Fayyaz A, Igoe A, Kurien BT et al (2015) Haematological manifestations of lupus. Lupus Sci Med 2:e78","journal-title":"Lupus Sci Med"},{"key":"364_CR18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/art.1780350821","volume":"35","author":"M Arenas","year":"1992","unstructured":"Arenas M, Abad A, Valverde V et al (1992) Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthritis Rheum 35:979\u2013980","journal-title":"Arthritis Rheum"},{"key":"364_CR19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/kel016","volume":"45","author":"D Mat\u00ednez-Ba\u00f1os","year":"2006","unstructured":"Mat\u00ednez-Ba\u00f1os D, Crisp\u00edn JC, Lazo-Langner A, S\u00e1nchez-Guerrero J (2006) Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology 45:994\u2013998","journal-title":"Rheumatology"},{"key":"364_CR20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0002-9343(00)00386-7","volume":"108","author":"G Starkebaum","year":"2000","unstructured":"Starkebaum G (2000) Leukemia of large granular lymphocytes and rheumatoid arthritis. Am J Med 108:744\u2013745","journal-title":"Am J Med"},{"key":"364_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM Klauw Van der","year":"1999","unstructured":"Van der Klauw MM, Goudsmit R, Halie MR et al (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 159:369\u2013374","journal-title":"Arch Intern Med"},{"key":"364_CR22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","volume":"71","author":"WG Dixon","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME et al (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a\u00a0nested case\u2013control analysis. Ann Rheum Dis 71:1128\u20131133","journal-title":"Ann Rheum Dis"},{"key":"364_CR23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2215\/CJN.07300712","volume":"8","author":"R Goupil","year":"2013","unstructured":"Goupil R, Brachemi S, Nadeau-Fredette AC, De ziel C, Troyanov Y, Lavergne V, Troyanov S (2013) Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis. Clin J Am Soc Nephrol 8:416\u2013423","journal-title":"Clin J Am Soc Nephrol"},{"key":"364_CR24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2012.05189.x","volume":"36","author":"T Bessissow","year":"2012","unstructured":"Bessissow T, Renard M, Hoffman I, Vermeire, Rutgeerts P, Van Assche G (2012) Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy. Aliment Pharmacol Ther 36:312\u2013323","journal-title":"Aliment Pharmacol Ther"},{"key":"364_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000377","volume":"29","author":"R Kado","year":"2016","unstructured":"Kado R, Sanders G, McCune WJ (2016) Suppression of normal immune responses after treatment with rituximab. Curr Opin Rheumatol 29:228\u2013233","journal-title":"Curr Opin Rheumatol"},{"key":"364_CR26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3899\/jrheum.130526","volume":"41","author":"R Abdulkader","year":"2014","unstructured":"Abdulkader R, Dharmapalaiah C, Rose G et al (2014) Late-onset neutropenia in patients with rheumatoid arthritis after treatment with rituximab. J\u00a0Rheumatol 41:858\u2013861","journal-title":"J Rheumatol"},{"key":"364_CR27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcs015","volume":"105","author":"E Besada","year":"2012","unstructured":"Besada E, Koldingsnes W, Nossent J (2012) Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a\u00a0case review analysis from a\u00a0single center. QJM 105:545\u2013550","journal-title":"QJM"},{"key":"364_CR28","doi-asserted-by":"crossref","first-page":"e000034","DOI":"10.1136\/rmdopen-2014-000034","volume":"1","author":"JH Salmon","year":"2015","unstructured":"Salmon JH, Cacoub P, Combe B et al (2015) Late-onset neutropenia after treatment & with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. RMD Open 1:e34","journal-title":"RMD Open"},{"key":"364_CR29","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/art.30427","volume":"63","author":"D Tesfa","year":"2011","unstructured":"Tesfa D, Ajeganova S, Hagglund H et al (2011) Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections. Arthr Rheum 63:2209\u20132214","journal-title":"Arthr Rheum"},{"key":"364_CR30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3899\/jrheum.150051","volume":"42","author":"RF Vollenhoven van","year":"2015","unstructured":"van Vollenhoven RF, Fleischmann RM, Furst DE et al (2015) Longterm safety of rituximab: final report of the Rheumatoid Arthritis Global Clinical Trial Programm over 11 years. J\u00a0Rheumatol 42:1761\u20131766","journal-title":"J Rheumatol"},{"key":"364_CR31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/annrheumdis-2016-210457","volume":"76","author":"SB Cohen","year":"2017","unstructured":"Cohen SB, Tanaka Y, Mariette X et al (2017) (Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials. Ann Rheum Dis 76:1253\u20131262","journal-title":"Ann Rheum Dis"},{"key":"364_CR32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/kew329","volume":"56","author":"H Schulze-Koops","year":"2017","unstructured":"Schulze-Koops H et al (2017) Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studies. Rheumatology 56:46","journal-title":"Rheumatology"},{"key":"364_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2011.01.006","volume":"10","author":"KA Newman","year":"2011","unstructured":"Newman KA, Akhtari M (2011) Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun Rev 10:432\u2013437","journal-title":"Autoimmun Rev"},{"key":"364_CR34","first-page":"645","volume":"45","author":"RH Aster","year":"1966","unstructured":"Aster RH et al (1966) Pooling of platelets in the spleen: role in the pathogenesis of \u201ehypersplenic\u201c. Thrombocytopenia Jclininvest 45:645\u2013657","journal-title":"Thrombocytopenia Jclininvest"},{"key":"364_CR35","first-page":"187","volume":"22","author":"I Uthman","year":"2008","unstructured":"Uthman I, Godeau B et al (2008) The hematologic manifestations of the antiphospholipid syndrome. BloodRev 22:187\u2013194","journal-title":"BloodRev"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0364-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0364-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0364-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T08:37:15Z","timestamp":1506933435000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0364-7"}},"subtitle":["An\u00e4mie, Leukopenie und Thrombopenie"],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":35,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0364-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}